AG真人官方

Liquidia Corporation (LQDA) 鈥� Form 4 insider transaction by CEO Roger Jeffs

The filing discloses two reportable events for the period 11-15 July 2025:

• 13,833 common shares acquired on 11-Jul-2025 through the vesting and settlement of performance stock units (transaction code M). The PSUs were part of a 221,338-unit grant dated 11-Jan-2024.
• 20,252 common shares sold on 14-Jul-2025 at $14.28 per share (transaction code S) under a Rule 10b5-1 trading plan. The sale was expressly for tax-withholding obligations linked to the earlier vesting of RSUs and PSUs.

After the transactions, Jeffs鈥� beneficial ownership stands at:

• 1,038,560 shares held directly
• 46,595 shares held indirectly via the Roger A. Jeffs Living Trust
• 1,541,667 shares held indirectly through Serendipity BioPharma LLC

He also retains significant unvested equity incentives: 108,562 RSUs from a 2023 grant, 138,336 RSUs from a 2024 grant, and 229,327 RSUs from a 2025 grant.

The net change is a decrease of 6,419 shares (鈮�0.2 % of his total beneficial ownership) and generates proceeds of roughly $289 thousand. Given the small size relative to his >2.6 million share stake and the pre-arranged 10b5-1 plan, the filing appears routine and tax-related rather than a directional signal.

Capital Research Global Investors (CRGI) filed Amendment No. 2 to Schedule 13G regarding its holdings in Hasbro, Inc. (HAS).

• Event date: 30 June 2025; filing dated 1 July 2025.
• Beneficial ownership: 5,027,509 common shares, equivalent to 3.6 % of Hasbro鈥檚 140,129,383 shares outstanding.
• Sole voting power: 5,024,697 shares; sole dispositive power: 5,027,509 shares; no shared voting or dispositive power.
• CRGI is an investment adviser (IA) and part of Capital Research and Management Company and its affiliates.
• The filing confirms the shares are held in the ordinary course of business and not for the purpose of influencing control.
• The position now stands below the 5 % ownership threshold; therefore CRGI is no longer considered a 5 % beneficial owner under SEC rules.

While CRGI remains a meaningful institutional holder, this amendment signals a reduced stake compared with prior filings, information that investors may weigh when assessing institutional sentiment toward Hasbro.

Rhythm Pharmaceuticals, Inc. (RYTM) 鈥� Form 4 insider filing

Director Camille L. Bedrosian reported the vesting of 4,000 restricted stock units (RSUs) on 18 June 2025 (transaction code M). Upon settlement, the RSUs converted into an equal number of common shares at no cash cost, increasing the director鈥檚 directly held common-stock position to 7,000 shares. No derivative securities remain outstanding from this grant, and no sales were disclosed. The filing was signed by attorney-in-fact Stephen Vander Stoep on 23 June 2025.

The transaction reflects routine equity compensation vesting rather than discretionary open-market buying or selling. Given the modest share count and automatic nature of the conversion, the event is considered immaterial to the company鈥檚 overall share structure and does not signal a change in strategic outlook or insider sentiment.

On 30 June 2025, Group President Todd Burrowes filed a Form 4 reporting an option exercise and immediate sale of Darden Restaurants (DRI) shares. He exercised 13,569 stock-option shares at an exercise price of $78.84 and sold the same number at a weighted-average price of $216.4493, realising an estimated pre-tax gain of about $1.9 million. The option, originally granted in July 2020 and fully vested by July 2024, now has zero remaining balance. Following the transaction, Burrowes still directly owns 46,326.616 shares, partly accumulated through the Employee Stock Purchase Plan and its dividend-reinvestment feature. No Rule 10b5-1 trading plan was noted. The filing represents routine insider portfolio management and is not expected to have a material impact on Darden鈥檚 operations or capital structure.